🇺🇸 FDA

P1 · Therapeutic area intelligence

Obesity & metabolic patent intelligence

GLP-1, GIP/GLP-1, diabetes, and metabolic disease patents — critical for obesity market IP tracking.

Patents
276

Quick answer

276 US pharmaceutical patents in our index match Obesity & metabolic title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7276352

    Induction of β cell differentiation in human cells by stimulation of the GLP-1 receptor

    The Regents of the University of California · Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7125965

    MRI probes of membrane potential

    The Regents of the University of California · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7118919

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7056734

    Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof

    The United States of America, as represented by the Department of Health and Human Services, N.I.H. · Granted Tue Jun 06 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7052691

    Methods of treating diabetes by blocking VEGF-mediated activity

    REGENERON PHARMACEUTICALS, INC. · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7033771

    Use of insulin response modulators in the treatment of diabetes and insulin resistance

    Takeda Pharmaceutical Company Limited · Granted Tue Apr 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6991908

    Antiobestic agents methods for screening antiobestic agents and kits comprising same

    Takeda Chemical Industries Ltd. · Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6933274

    Methods for treatment of diabetes using a peptide analogues of insulin

    Neurocrine Biosciences, Inc. · Granted Tue Aug 23 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6884585

    Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor

    The Regents of the University of California · Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6878550

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6787321

    Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products

    The Regents of the University of California · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6777435

    Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

    Takeda Chemical Industries Ltd. · Granted Tue Aug 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6686338

    Enzyme inhibitors for metabolic redirection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6673778

    Enzyme inhibitors for metabolic redirection

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6649594

    Compositions for metabolic protection and repair of lips

    The Regents of the University of California · Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6602715

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Aug 05 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6599750

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6562942

    Methods for treatment of diabetes using peptide analogues of insulin

    Neurocrine Biosciences, Inc. · Granted Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6515003

    Heterocyclic derivatives for the treatment of diabetes and other diseases

    Maxim Pharmaceuticals, Inc. · Granted Tue Feb 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6468802

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6461870

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Isotechnika, Inc. · Granted Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6458782

    Remedies for diabetes

    Institute of Medicinal Molecular Design, Inc. · Granted Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6391651

    Materials and methods for detection of insulin dependent diabetes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6365401

    Method and probes for the identification of microbial genes specifically induced during host infection

    The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6365138

    Compositions for metabolic protection and repair of lips

    The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6329403

    Pharmaceutical composition for the treatment of diabetes

    Takeda Chemical Industries Ltd. · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6328959

    Intestinal hydrogen removal using hydrogen-metabolizing microbes

    United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6207159

    Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

    The Regents of the University of California · Granted Tue Mar 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6197926

    Methods for treatment of diabetes using peptide analogues of insulin

    Neurocrine Biosciences, Inc. · Granted Tue Mar 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6146653

    Pharmaceutical preparation and a method for the treatment of diabetes

    Diataranz Limited · Granted Tue Nov 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6133320

    Treatment of osteoporosis and metabolic bone disorders with nitric oxide substrate and/or donors

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6127598

    NKX-2.2 and NKX-6.1 transgenic mouse models for diabetes, depression, and obesity

    The Regents of the University of California · Granted Tue Oct 03 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6117867

    Substituted 6-R-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetizing, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them

    Nauchno-Tekhnologicheskoe Predpriyatie Ligand (Tovarischestvo S Ogranichennoi Otvetstvennostiju) · Granted Tue Sep 12 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6034109

    Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia

    The Regents of the University of California · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6028068

    Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them

    Nauchno-Tekhnologicheskoe Predpriyatie Ligand (Tovarischestvo S Ogranichennoi Otvetstvennostiju) · Granted Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6022697

    Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus

    The Regents of the University of California · Granted Tue Feb 08 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Obesity & metabolic patents are indexed?

276 patents match our Obesity & metabolic classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.